FDA Approves Expanded Uses for GARDASIL in Preventing Cancer

Tags:
Merck Gardasil HPV Vaginal Cancer Vulvar Cervical Genitals Warts Supplemental Biologics License
Edit Video Details Toggle Wide Screen Mode
NewsInfusion
  • By: NewsInfusion
  • Subscribers: 3
  • Updated: 05-Feb-10
  • Videos: 233
  • International International
  • Comments: 0
  • Views: 253
  • Added: 17-Sep-08

September 12, 2008 – The U.S. Food and Drug Administration today announced the approval of the vaccine GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant] for the prevention of vaginal and vulvar cancer caused by Human Papillomavirus (HPV) types 16 and 18 in girls and women ages 9 to 26. These two HPV types cause 70 percent of cervical cancers, and are known to also cause some vulvar and vaginal cancers, but the percentages are not well defined.

  1. Categories: Science & Tech
Comments on

FDA Approves Expanded Uses for GARDASIL in Preventing Cancer

0 Comments | Be the first to comment